Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -486.83% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTSeaStar Medical Holding Corp's latest supported as-filed period reports revenue of $615,000; gross margin moved 79 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -486.83% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 81.95% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 12.52% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 91.22% · CORE
Level · gp.fundamentals.operating_margin
Raw value -616.42% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 409.76% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Gross margin changed -79 basis points from the comparable as-filed period.
Gross profit changed +80.4% from the comparable as-filed period.
Inventory changed +0.0% from the comparable as-filed period.
Net income changed -86.3% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
ICU · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001437749-26-028540SEC ↗10-QAug 12, 2026Period Jun 30, 20260001437749-26-027353SEC ↗8-KAug 12, 2026Period Aug 12, 20260001437749-26-027314SEC ↗4Jul 2, 2026Period Jul 1, 20260001437749-26-022573SEC ↗4Jul 2, 2026Period Jul 1, 20260001437749-26-022569SEC ↗4Jul 2, 2026Period Jul 1, 20260001437749-26-022567SEC ↗4Jul 2, 2026Period Jul 1, 20260001437749-26-022566SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 18, 2026Filed Aug 19, 2026 | Messinger MichaelChief Financial Officer | Open Market PurchaseDirect | 750 | $3 | $2,453 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value -16.10% · OPTIONAL
Operating income changed -115.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -9690 basis points from the comparable as-filed period.
Research & development changed +143.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001437749-26-022565